LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (NASDAQ: CBRX) announced today it has entered into an agreement with DesignRxclusive LLC to improve access to CRINONE® 8% (progesterone gel) for patients without insurance or whose benefits do not cover this product. Under this agreement, CRINONE 8% will be the only branded vaginal progesterone on the DesignRxclusiveSM formulary.
